Cancer Australia has undertaken an analysis of MBS data on cancer-related medical services and procedures to understand the impact of the COVID-19 pandemic on cancer.
Substantial reductions in medical services and procedures relating to cancer investigations and treatment have been reported by service providers in Australia in response to the COVID-19 pandemic.
Cancer Australia has undertaken an analysis of a range of services reimbursed through the MBS for the months January 2020 to June 2020 to understand where any reductions in cancer-related services have occurred, and the types of services affected.
Analyses focussed on:
- MBS item numbers for cancer-related diagnostic and treatment procedures
- New telehealth MBS items available during the COVID-19 pandemic.
The findings are published in a new report titled Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: Skin, breast and colorectal cancers, and telehealth services. (PDF 1 MB)
Initial analyses showed national reductions in total monthly services for diagnostic and therapeutic procedures during the initial COVID-19 period between March and May 2020. The monthly data for some services showed an initial recovery in May, with many services showing further recovery in numbers by June 2020.